电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

HIV-1 p24 抗体

The 小鼠 单克隆 anti-HIV-1 p24 antibody (Clone E12) (ABIN7849766) specifically detects HIV-1 p24 in ELISA. The antibody is reactive with 人 samples.
产品编号 ABIN7849766
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for HIV-1 p24 抗体 (ABIN7849766)

抗原

See all HIV-1 p24 抗体
HIV-1 p24 (Human Immunodeficiency Virus 1 Capsid (HIV-1 p24))

适用

  • 67
  • 8
  • 6
  • 1
  • 1

宿主

  • 45
  • 18
  • 15
  • 1
  • 1
  • 1
小鼠

克隆类型

  • 47
  • 29
单克隆

标记

  • 47
  • 10
  • 9
  • 6
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HIV-1 p24 antibody is un-conjugated

应用范围

  • 62
  • 50
  • 23
  • 15
  • 10
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA

克隆位点

E12
  • 原理

    Monoclonal Anti- HIV-1 p24 (Detection Ab)

    产品特性

    This antibody may be used as in antibody pair experiments such as ELISA.

    纯化方法

    Protein A or G purified

    纯度

    >95 % by HPLC & SDS-PAGE

    免疫原

    Recombinant human HIV-1 p24 Protein (Expression system with E.Coli).

    亚型

    IgG
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    0.9 % NaCl without preservative.

    储存液

    Without preservative

    注意事项

    Avoid repeated freeze and thaw cycles.

    储存条件

    -20 °C

    储存方法

    Aliquot and store at -20°C for long term (at least for one year). Avoid repeated freeze and thaw cycles.

    有效期

    12 months
  • 抗原

    HIV-1 p24 (Human Immunodeficiency Virus 1 Capsid (HIV-1 p24))

    别名

    HIV-1 p24

    物质类

    Viral Protein

    背景

    Acquired immune deficiency syndrome (HIV/AIDS) has been a major global health concern for over 38 years. No safe and effective preventive or therapeutic vaccine has been developed although many products have been investigated. Computational methods have facilitated vaccine developments in recent decades. Among HIV-1 proteins, p24 and Nef are two suitable targets to provoke the cellular immune response. The predicted fusion protein, p24-AAY-Nef in a truncated form with a high rate of T cell epitopes and high conservancy rate among different clades, provides a helpful model for developing a therapeutic vaccine candidate against HIV-1. HIV-1 infection of macrophages leads to the sequestration of newly formed viruses in intracellular plasma membrane-connected structures termed virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. HIV-1 infection of macrophages leads to the sequestration of newly formed viruses in virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The transmembrane domain of Vpu and two motifs of the Vpu cytoplasmic domain are required for these functions. These motifs were notably involved in the control of the volume of VCCs by Vpu but were dispensable for the prevention of the specific accumulation of BST2 in these structures.
You are here: